glp 1 latest news GLP-1 Pipeline Update: May 2026 - Prime Therapeutics New studies find that GLP-1
Description
Secondary outcomes included the individual components of the composite outcome and pancreatic cancer
SEATTLE &mdash
Healthier insulin response
Backed by Science
Results are less dramatic than injectable medications, but a manufacturer has signalled intent to apply for approval in the US.
